The above results indicated that baicalin magnesium can inhibit the inflammatory response and exert therapeutic effects on NASH rats by inhibiting the activation of NLRP3/caspase-1/IL-1β inflammatory pathway. This evidence concerns the gene CASP1 and metabolic dysfunction-associated steatohepatitis.